News - Vaccines


Current filters:


Popular Filters

226 to 250 of 258 results

New global data on influenza vaccine provision and level of support for immunization policies


The findings of two studies being published this week in peer-reviewed journals look at global vaccination…

GlobalHealthcarePharmaceuticalRespiratory and PulmonaryVaccines

Stronger incentives for immunization of children in Australia


Australia’s childhood immunization arrangements are to be reformed with the aim of increasing the…


Indian vaccine market targets $4.6 billion revenue by 2017, up from current $900 million


The Indian vaccine market is currently estimated to be worth around $900 million and targets $4.6 billion…

Asia-PacificMarkets & MarketingPharmaceuticalResearchVaccines

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results


French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…


Hepatitis B vaccines market forecast to show moderate growth until 2018


The global hepatitis B vaccines market is estimated to be worth $997.0 million in 2010, and is forecast…

Anti-viralsGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalVaccines

Russia’s RusNano invests in Selecta and BIND to develop and commercialize vaccines and cancer drugs


Two USA-based nano-medicines companies, BIND Biosciences and Selecta Biosciences, have entered into investment…

BIND BiosciencesBiotechnologyFinancialOncologyResearchRusNanoSelecta BiosciencesVaccines

Activartis develops dendritic cell-based cancer vaccine in Ph II; will seek partner


Privately-held Austrian company Activartis GmbH (formerly Trimed Biotech) is developing a cancer immunotherapy…


Gilead collaborates with GlobeImmune to develop vaccine for chronic hepatitis B infection


Gilead Sciences (Nasdaq: GILD) has entered into an exclusive worldwide license and collaboration agreement…

Anti-viralsBiotechnologyGilead SciencesGlobeImmuneLicensingResearchVaccines

Cancer vaccines market set to see change, will grow to over $9 billion by 2018


The global cancer vaccines market in seven key markets (the USA, France, Germany, Italy, Spain, UK and…

CervarixDendreonGardasilGlaxoSmithKlineGlobalMarkets & MarketingMerck & CoOncologyPharmaceuticalProvengeVaccines

GlaxoSmithKline warned by US FDA over cGMP violations at UK plant; positive malaria vaccine news


UK pharma giant GlaxoSmithKline ILSE: GSK) has received a warning letter from the US Food and Drug Administration…

Antibiotics and Infectious diseasesGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

Sinovac awarded contract to supply Anflu flu vaccine to Beijing CDC


Chinese biopharmaceuticals company Sinovac Biotech (Nasdaq: SVA) saw its share price jump 12% to $2.49…

AnfluAsia-PacificBiotechnologyMarkets & MarketingSinovacVaccines

Scripps scientists’ findings could advance AIDS vaccine development


Researchers at the USA-based Scripps Research Institute have uncovered the surprising details of how…


Global vaccines market to be worth $20.8 billion in 2015, says Visiongain


The worldwide vaccines market will reach a value of $20.8 billion in 2015, nearly double the $10.7 billion…

GlobalMarkets & MarketingPharmaceuticalVaccines

Biotron shares leap 29% on hepatitis C Ph IIa positive results; Inovio advances hepatitis vaccines


Australian firm Biotron (ASX: BIT) has received some strong support in the first couple of hours of market…

Anti-viralsBiotronInovio PharmaceuticalsLicensingPharmaceuticalResearchVaccinesVGX International

Sanofi oral MS drug Aubagio shows strong efficacy in Ph III trial; plans massive Indian vaccine plant


French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme says that the results of a pivotal…


Emergent BioSolutions gets $1.25 billion BioThrax order for US government


Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government…

BioThraxEmergent BioSolutionsFinancialMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Cost benefit analysis of cervical cancer vaccines sees Gardasil beat Cervarix


An analysis of cervical-cancer vaccine has shown that Merck & Co’s (NYSE: MRK) Gardasil (human papillomavirus…

CervarixEuropeGardasilGlaxoSmithKlineMerck & CoPharmaceuticalPricingVaccines

GAVI Alliance delivers on its promise to tackle diarrhea and pneumonia


The GAVI Alliance announced this week that it will provide funding for 16 more developing countries to…


Daiichi Sankyo admits supply problem with flu vaccine; gains approval for silodosin in China


Japanese drug major Daiichi Sankyo (TYO: 4568) announced this week that its domestic subsidiary, Kitasato…

Asia-PacificDaiichi SankyoMarkets & MarketingOncologyPharmaceuticalRegulationsilodosinVaccines

Sanofi Pasteur enters $3 billion acne treatment market in deal with UC San Diego


Moving into a new therapeutic sector, Sanofi Pasteur, the vaccines division of French drug major Sanofi…

LicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

RXi Pharma in-licenses targeted vaccine for gynecological cancers


US biotech firm RXi Pharmaceuticals (Nasdaq: RXII) has licensed worldwide rights to develop and commercialize…

LicensingOncologyResearchRXi PharmaceuticalsVaccines

226 to 250 of 258 results

Back to top